The MTERFD3 Polyclonal Antibody (CAB8518) is a valuable tool for research involving the MTERFD3 protein, a key player in mitochondrial gene expression and maintenance. This antibody, produced in rabbits, exhibits high reactivity with human samples and has been validated for use in Western blot applications. By specifically binding to the MTERFD3 protein, this antibody enables accurate detection and analysis in a variety of cell types, making it an ideal choice for studies in mitochondrial biology and related fields.MTERFD3 is a crucial factor in the regulation of mitochondrial gene transcription and replication, impacting cellular energy production and overall mitochondrial function.
Understanding the role of MTERFD3 is essential for unraveling the complexities of mitochondrial biology and its implications in various diseases, including metabolic disorders and neurodegenerative conditions. The MTERFD3 Polyclonal Antibody provides researchers with a reliable tool for investigating the function and regulation of this important protein, ultimately paving the way for advancements in mitochondrial research and potential therapeutic strategies.
Product Name:
MTERFD3 Rabbit Polyclonal Antibody
SKU:
CAB8518
Size:
20uL, 100uL
Isotype:
IgG
Host Species:
Rabbit
Reactivity:
Human,Mouse,Rat
Immunogen:
Recombinant fusion protein containing a sequence corresponding to amino acids 1-250 of human MTERFD3 (NP_079474.2).
Enables DNA binding activity. Predicted to be involved in termination of mitochondrial transcription. Located in mitochondrion.
Purification Method:
Affinity purification
Gene ID:
80298
Storage Buffer:
Store at -20℃. Avoid freeze / thaw cycles.Buffer: PBS with 0.02% sodium azide,50% glycerol,pH7.3.
Western blot analysis of extracts of various cell lines, using MTERFD3 antibody (CAB8518) at 1:1000 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (CABS014) at 1:10000 dilution.Lysates/proteins: 25μg per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit (AbGn00020).Exposure time: 180s.
